ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Sorafenib in combination with paclitaxel for locally recurrent or metastatic bre...
Prof William Gradishar - Robert H. Lurie Comprehensive Cancer Center, USA
A novel strategy in treating endocrine resistance using combination therapy
Dr Rajeshwar Rao Tekmal - University of Texas Health Science Center, San Antonio...
Lapatinib alone or in combination with trastuzumab for HER2+ metastatic breast c...
Dr Kimberly Blackwell - Duke University Medical Center, USA
Bevacizumab in combination with chemotherapy for second-line treatment of HER2-n...
Prof Adam Brufsky - University of Pittsburgh Cancer Institute, USA
Bevacizumab plus docetaxel compared with placebo plus docetaxel for locally recu...
Dr David Miles - Mount Vernon Hospital, United Kingdom
Exemestane vs tamoxifen followed by exemestane
Dr Daniel Rea - University of Birmingham, UK
Adult acute lymphoblastic leukaemia
Prof Anthony Goldstone - Director, North London Cancer Network
Using biology of tumours to predict effective therapies
Dr Laura Van`t Veer - The Netherlands Cancer Institute, Amsterdam, The Netherlan...
Translation of endocrine systemic treatment
Prof Giuseppe Viale - European Institute of Oncology, Milan, Italy
Dr Catherine Bollard - Baylor College of Medicine, Texas, USA
The International Consortium on Acute Promyelocytic Leukemia
Dr Eduardo Rego - University of Sao Paulo, Brazil
Myeloid supressor cells
Prof John Harlan - University of Washington, USA